Related Experiment Videos
Neuroprotective effects of Ginkgo biloba extract
1Institut für Pharmakologie und Toxikologie, Fachbereich Pharmazie der Philipps-Universität Marburg, Ketzerbach 63, 35032 Marburg, Germany.
Cellular and Molecular Life Sciences : CMLS
|October 3, 2003
Summary
Ginkgo biloba extract (EGb 761) enhances blood flow and offers neuroprotection through compounds like flavonoids. This review details its mechanisms, animal study results, and clinical trial status for dementia treatment.
Area of Science:
- Pharmacology
- Neuroscience
- Herbal Medicine
Background:
- Ginkgo biloba extract (EGb 761) is widely used for improving blood flow and treating dementia.
- Its therapeutic effects are attributed to flavonoids and terpenoids, known for neuroprotective and vasotropic properties.
Purpose of the Study:
- To review the mechanisms of neuroprotection by Ginkgo biloba extract (EGb 761) and its constituents.
- To summarize experimental findings, primarily from animal studies, on EGb 761's effects.
- To discuss the current clinical trial status and side effects of EGb 761.
Main Methods:
- Literature review of experimental results on Ginkgo biloba extract (EGb 761).
- Focus on studies investigating neuroprotective mechanisms and effects on cerebral blood flow.
- Inclusion of animal studies and discussion of clinical trial data.
Main Results:
- EGb 761 impacts cerebral blood flow, neurotransmitter systems, cellular redox state, and nitric oxide levels.
- Experimental data primarily from animal models supports EGb 761's neuroprotective effects.
- Clinical trial data and safety profiles are also considered.
Conclusions:
- Ginkgo biloba extract (EGb 761) demonstrates neuroprotective mechanisms relevant to dementia treatment.
- Further clinical evaluation is ongoing to confirm efficacy and safety.
- The extract's constituents contribute to its therapeutic actions on the brain and vasculature.